| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | A nucleoside analogue in which the nucleobase portion is a 1,4,5,6,8-pentaazaacenaphthylene ring system substituted with an amino group at position 3, and a methyl group at position 5 and is bound to the beta-D-ribofuranosyl moiety by an N(1)-glycosidic linkage. (Chemical Entities of Biological Interest Ontology, CHEBI_65310) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=TRICIRIBINE |
| Similar Terms | |
| Downloads & Tools |
6 interacting proteins for the TRICIRIBINE drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| ZNF217 | zinc finger protein 217 | 21.1728 |
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.588133 |
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.504114 |
| AKT3 | v-akt murine thymoma viral oncogene homolog 3 | 0.4812 |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.387307 |
| NFE2L2 | nuclear factor, erythroid 2-like 2 | 0.0629393 |